Frontlight ResearchEarly access
Trial site
Mammazentrum Hamburg MVZ GbR
- 17running trials
- 2closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer10 trials
- Triple-negative breast cancer6 trials
- Ovarian cancer3 trials
- Phase
- Phase 315 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Recruiting12 trials
- Active, not recruiting5 trials
- Completed2 trials
- Lead sponsor
- AstraZeneca3 trials
- Hoffmann-La Roche2 trials
- AGO Research GmbH1 trial
- AGO Study Group1 trial
- AstraZeneca AB1 trial
- and 11 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer5 recruiting
- Triple-negative breast cancer4 recruiting
- Ovarian cancer3 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026